Dual Targeting of BCL-2 and MCL-1 in the Presence of BAX Breaks Venetoclax Resistance in Human Small Cell Lung Cancer

Scientists revealed the subtype specificity of BCL-2 expression and shed light on the mechanism of venetoclax resistance in SCLC.